SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-12-067422
Filing Date
2012-02-17
Accepted
2012-02-17 16:06:00
Documents
6
Period of Report
2011-07-15
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d301577d8ka.htm 8-K/A 19832
2 CONSENT OF INDEPENDENT AUDITOR d301577dex231.htm EX-23.1 1615
3 AUDITED SPECIAL-PURPOSE STATEMENT OF ASSETS (ORTHO DERMATOLOGICS) d301577dex991.htm EX-99.1 133648
4 UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENTS OF INCOME d301577dex992.htm EX-99.2 339044
5 GRAPHIC g301577g59t12.jpg GRAPHIC 2032
6 GRAPHIC g301577g75m45.jpg GRAPHIC 3687
  Complete submission text file 0001193125-12-067422.txt   503678
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-14956 | Film No.: 12622734
SIC: 2834 Pharmaceutical Preparations